|
Noam Mandel
Noam Mandel received his B.S.F.S. from Georgetown University in 1998 and his J.D.,
cum laude, from Boston University School of Law in 2002 where he served as an Editor for the
Boston University Law
Review and won awards in civil procedure, evidence, and international law. While in law school, he also participated in
an exchange program with the University of Leiden, The Netherlands, where he concentrated his studies on international
and comparative law.
Mr. Mandel prosecutes securities fraud, corporate governance and shareholder rights
litigation for the firm’s institutional investor clients. He has been a member of the litigation teams on several of
the firm’s recent high profile cases including
In re Nortel Networks Corporation Securities Litigation, which resulted in
a recovery worth in excess of $1.3 billion in cash and stock, as well as the securities class action against the
Federal Home Loan Mortgage Corporation ("Freddie Mac"), in which a $410 million settlement was obtained for defrauded
investors. More recently, he was a member of the team that prosecuted the
Caremark Merger Litigation, a shareholder
class action contesting the terms of a proposed merger between Caremark Rx, Inc. and CVS Corporation on behalf of Caremark's
shareholders. The litigation resulted in over $3 billion in additional consideration being offered to Caremark shareholders
by CVS.
Prior to joining BLB&G, Mr. Mandel was a litigation associate at Simpson Thacher & Bartlett LLP,
where his practice focused on securities, shareholder and ERISA fiduciary matters.
ADMISSIONS: Mr. Mandel is admitted to bar of the
State of New York and the United States District Court,
Southern District of New York.
|
